Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Cytokeratin 5 antibody

This anti-Cytokeratin 5 antibody is a Mouse Monoclonal antibody detecting Cytokeratin 5 in IHC and ELISA. Suitable for Human. This Primary Antibody has been cited in 2+ publications.
Catalog No. ABIN969078

Quick Overview for Cytokeratin 5 antibody (ABIN969078)

Target

See all Cytokeratin 5 (KRT5) Antibodies
Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))

Reactivity

  • 148
  • 85
  • 57
  • 12
  • 11
  • 11
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 108
  • 54
  • 2
Mouse

Clonality

  • 93
  • 71
Monoclonal

Conjugate

  • 74
  • 17
  • 12
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Cytokeratin 5 antibody is un-conjugated

Application

  • 102
  • 77
  • 47
  • 32
  • 30
  • 27
  • 18
  • 14
  • 13
  • 13
  • 10
  • 9
  • 6
  • 5
  • 4
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (IHC), ELISA

Clone

3E2F1
  • Purpose

    Cytokeratin 5 Antibody

    Purification

    Ascitic fluid

    Immunogen

    Purified recombinant fragment of CK5 expressed in E. Coli.

    Isotype

    IgG1
  • Application Notes

    ELISA: 1/10000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Ascitic fluid containing 0.03 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Canedo-Patzi, León-Bojorge, de Ortíz-Hidalgo: "[Adenomatoid tumor of the genital tract. Clinical, pathological and immunohistochemical study in 9 cases]." in: Gaceta médica de México, Vol. 142, Issue 1, pp. 59-66, (2006) (PubMed).

    Leibl, Moinfar: "Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation." in: The American journal of surgical pathology, Vol. 30, Issue 4, pp. 450-6, (2006) (PubMed).

  • Target

    Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))

    Alternative Name

    Cytokeratin 5

    Background

    CK5 (keratin 5) is a member of the keratin gene family. Biochemically, most members of the CK family fall into one of two classes, type I (acidic polypeptides) and type II (basic polypeptides). The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. The type II cytokeratins are clustered in a region of chromosome 12q12-q13. At least one member of the acidic family and one member of the basic family is expressed in all epithelial cells. Cytokeratin 5 is expressed in normal basal cells. Mutations of the Cytokeratin5 gene (KRT5) have been shown to result in the autosomal dominant disorderepidermolysis bullosa (EB). Defects in KRT5 are a cause of epidermolysis bullosa simplex.

    Gene ID

    3852

    UniProt

    P13647
You are here:
Chat with us!